Update on PD-1/PD-L1 inhibitors in multiple myeloma
This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) and the copyright owner(s) are credited and that the original publication
in this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.
Jelinek, T. (T.); Paiva, B. (Bruno); Hajek, R. (R.). "Update on PD-1/PD-L1 inhibitors in multiple myeloma". Frontiers in immunology. 9, 2018, 2431
Statistics and impact
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.